VKTX logo

VKTX
Viking Therapeutics Inc

38,137
Mkt Cap
$3.91B
Volume
2.04M
52W High
$43.15
52W Low
$18.92
PE Ratio
-10.63
VKTX Fundamentals
Price
$33.84
Prev Close
$32.97
Open
$32.16
50D MA
$32.35
Beta
1.54
Avg. Volume
3.46M
EPS (Annual)
-$3.19
P/B
6.08
Rev/Employee
$0.00
$3,258.03
Loading...
Loading...
News
all
press releases
Viking Therapeutics, Inc. $VKTX Shares Sold by Vanguard Group Inc.
Vanguard Group Inc. lowered its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 1.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·13h ago
News Placeholder
More News
News Placeholder
Viking Therapeutics (NASDAQ:VKTX) Upgraded at BTIG Research
BTIG Research raised Viking Therapeutics to a "strong-buy" rating in a research note on Thursday...
MarketBeat·2d ago
News Placeholder
Why the Market Dipped But Viking Therapeutics, Inc. (VKTX) Gained Today
Viking Therapeutics, Inc. (VKTX) reached $33.84 at the closing of the latest trading day, reflecting a +2.64% change compared to its last close.
Zacks·2d ago
News Placeholder
Viking Therapeutics: The High-Stakes Weight Loss Contender
Viking Therapeutics is positioning itself as a contender in the obesity market with a dual strategy of rapid clinical progress and commercial preparation...
MarketBeat·3d ago
News Placeholder
Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead?
LLY's Mounjaro and Zepbound drove 56% of revenues in 2025 as obesity demand surged, with new launches and Medicare access set to fuel growth.
Zacks·4d ago
News Placeholder
Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026
LLY or NVO? With surging GLP-1 sales, oral obesity pills and diverging 2026 outlooks, the obesity drug race is entering a pivotal new phase.
Zacks·5d ago
News Placeholder
Got $5,000? Viking Therapeutics Might Be a Weight Loss Drug Moon Shot in the Making.
Key PointsViking Therapeutics' leading candidate posted strong mid-stage data and is undergoing phase 3 studies...
Nasdaq News: Markets·6d ago
News Placeholder
Noteworthy Monday Option Activity: VKTX, WMB, EVTC
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Viking Therapeutics Inc (Symbol: VKTX), where a total volume of 21,067 contracts...
Nasdaq News: Markets·6d ago
News Placeholder
Viking Therapeutics Stock Gains Amid Obesity Drug Buzz
Viking shares rise after Novo's REDEFINE 4 trial trails Lilly's tirzepatide in weight loss.read more...
Benzinga·6d ago
News Placeholder
Viking Therapeutics (NASDAQ:VKTX) Shares Gap Up - What's Next?
Viking Therapeutics (NASDAQ:VKTX) Shares Gap Up - Time to Buy...
MarketBeat·6d ago
<
1
2
...
>

Latest VKTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.